TCF3 and neoplasm: Given that EMT has been shown to markedly diminish the sensitivity of tumor cells to chemotherapeutic agents, including DOX [107,108], we propose that observed overexpression of TCF3 in DOX-resistant cells (Figure 4B) may be linked to their partial mesenchymal phenotype.